Klotho protein: a new insight into the pathogenesis of essential hypertension
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Essential hypertension is a most prevalent global health concern. Despite extensive research, the exact mechanisms contributing to essential hypertension remain unclear. Several factors contribute to the pathogenesis of essential hypertension. Klotho, a membrane-bound and soluble protein, has been found to modulate hypertension through physiological processes like vascular function and sodium balance. This study aimed to determine the association of klotho protein with essential hypertension.The study included 164 hypertensive cases and 164 normotensive controls, after imposing certain inclusion and exclusion criteria with written consent from all subjects. Subject’s details were obtained using structured proforma to account for potential confounding variables. To estimate klotho protein activity using sandwich enzyme-linked immunosorbent assay, 2 mL blood was collected in a plain vial. All data were tested at a 5% significance level. The analysis revealed a significant decrease in klotho protein levels in cases compared to controls (1.52 ± 0.87 vs. 2.45 ± 0.90, P < 0.001), suggesting an inverse relationship of klotho protein with risk of essential hypertension. All indices in the structural equation model have suggested that the final model fitted the data reasonably (chi-square to df ratio, 1.153; goodness of fit index, 0.990; adjusted goodness of fit index, 0.945; normed fit index, 0.936; standardized root mean square residual, 0.953; root mean square error of approximation, 0.031). Also, klotho was negatively associated with blood pressure. The area under the receiver operating characteristic curve for klotho and blood pressure was 0.765 (95% confidence interval, 0.716–0.815; P < 0.001). Klotho levels were significantly reduced in essential hypertension cases compared to controls, Also, klotho had a negative direct association with essential hypertension indicating a potential role for klotho as a prognostic and predictive marker for essential hypertension. This suggests that klotho may have a role in the pathogenesis of essential hypertension. Understanding klotho’s role in essential hypertension may lead to the development of novel therapeutic strategies for this disease.
Abstract
Background Essential hypertension is a most prevalent global health concern. Despite extensive research, the exact mechanisms contributing to essential hypertension remain unclear. Several factors contribute to the pathogenesis of essential hypertension. Klotho, a membrane-bound and soluble protein, has been found to modulate hypertension through physiological processes like vascular function and sodium balance. This study aimed to determine the association of klotho protein with essential hypertension. Methods The study included 164 hypertensive cases and 164 normotensive controls, after imposing certain inclusion and exclusion criteria with written consent from all subjects. Subject’s details were obtained using structured proforma to account for potential confounding variables. To estimate klotho protein activity using sandwich enzyme-linked immunosorbent assay, 2 mL blood was collected in a plain vial. All data were tested at a 5% significance level. Results The analysis revealed a significant decrease in klotho protein levels in cases compared to controls (1.52±0.87 vs. 2.45±0.90, P<0.001), suggesting an inverse relationship of klotho protein with risk of essential hypertension. All indices in the structural equation model have suggested that the final model fitted the data reasonably (chi-square to df ratio, 1.153; goodness of fit index, 0.990; adjusted goodness of fit index, 0.945; normed fit index, 0.936; standardized root mean square residual, 0.953; root mean square error of approximation, 0.031). Also, klotho was negatively associated with blood pressure. The area under the receiver operating characteristic curve for klotho and blood pressure was 0.765 (95% confidence interval, 0.716–0.815; P<0.001). Conclusions Klotho levels were significantly reduced in essential hypertension cases compared to controls, Also, klotho had a negative direct association with essential hypertension indicating a potential role for klotho as a prognostic and predictive marker for essential hypertension. This suggests that klotho may have a role in the pathogenesis of essential hypertension. Understanding klotho’s role in essential hypertension may lead to the development of novel therapeutic strategies for this disease
참고문헌 (36)
- Kanbay M, "Role of klotho in the development of essential hypertension", Hypertension, 77, pp.740~750 (2021)
- Sun Z, "Aging, arterial stiffness, and hypertension", Hypertension, 65, pp.252~256 (2015)
- Harvey A, "Vascular biology of ageing : implications in hypertension", J Mol Cell Cardiol, 83, pp.112~121 (2015)
- Kuro-o M, "Klotho in health and disease", Curr Opin Nephrol Hypertens, 21, pp.362~368 (2012)
- Pathare G, "α-Klotho and catalase expression in essential hypertension", Integr Mol Med, 7, pp.1~6 (2020)
- Edmonston D, "FGF23 and klotho at the intersection of kidney and cardiovascular disease", Nat Rev Cardiol, 21, pp.11~24 (2024)
- Maltese G, "The putative role of the antiageing protein klotho in cardiovascular and renal disease", Int J Hypertens, 2012, pp.757469~ (2012)
- Bernheim J, "The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases", Nephrol Dial Transpl, 26, pp.2433~2438 (2011)
- Hu MC, "Fibroblast growth factor 23 and Klotho : physiology and pathophysiology of an endocrine network of mineral metabolism", Annu Rev Physiol, 75, pp.503~533 (2013)
- Chen CD, "Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10and ADAM17", Proc Natl Acad Sci U S A, 104, pp.19796~19801 (2007)
- Bloch L, "Klotho is a substrate for alpha-, beta-and gamma-secretase", FEBS Lett, 583, pp.3221~3224 (2009)
- van Loon EP, "Shedding of klotho by ADAMs in the kidney", Am J Physiol Ren Physiol, 309, pp.F359~F368 (2015)
- Chen CD, "Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho", PLoS ONE, 15, pp.e0226382~ (2020)
- Silswal N, "FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability", Am J Physiol Endocrinol Metab, 307, pp.E426~E436 (2014)
- Richter B, "Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells", Pflugers Arch, 468, pp.1621~1635 (2016)
- Chung CP, "α-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells", PLoS ONE, 12, pp.e0176817~ (2017)
- Bell K, "Hypertension : the silent killer : updated JNC-8 guideline recommendations", Ala Pharm Assoc, 334, pp.4222~ (2015)
- Bentler PM, "Comparative fit indexes in structural models", Psychol Bull, 107, pp.238~246 (1990)
- Hu L, "Cutoff criteria for fit indexes in covariance structure analysis : conventional criteria versus new alternatives", Struct Equ Model, 6, pp.1~55 (1999)
- Alam R, "Evaluation of microalbuminuria in patients with hypertension from north Indian population : a case-control study", Int J Clin Biochem Res, 5, pp.271~276 (2018)
- Karalliedde J, "Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria", Clin J Am Soc Nephrol, 8, pp.1899~1905 (2013)
- Saito Y, "In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome", Biochem Biophys Res Commun, 276, pp.767~772 (2000)
- Nagai R, "Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases", Cell Mol Life Sci, 57, pp.738~746 (2000)
- Shroff R, "Klotho : an elixir of youth for the vasculature?", J Am Soc Nephrol, 22, pp.5~7 (2011)
- Drew DA, "Soluble klotho and incident hypertension", Clin J Am Soc Nephrol, 16, pp.1502~1511 (2021)
- Guzik TJ, "Oxidative stress, inflammation, and vascular aging in hypertension", Hypertension, 70, pp.660~667 (2017)
- Mishra P, "Evaluation of oxidative stress and dyslipidemia in diagnosed hypertensive patients", Biochem Cell Arch, 19, pp.3867~3872 (2019)
- Hu MC, "Klotho deficiency causes vascular calcification in chronic kidney disease", J Am Soc Nephrol, 22, pp.124~136 (2011)
- Münzel T, "Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction", Ann Med, 40, pp.180~196 (2008)
- Quyyumi AA, "Endothelial function in health and disease : new insights into the genesis of cardiovascular disease", Am J Med, 105, pp.S32~S39 (1998)
- Zhou X, "Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1", CC chemokine receptor 2-mediated inflammation, 2015, pp.26, 121~132
- Takenaka T, "Klotho ameliorates medullary fibrosis and pressure natriuresis in hypertensive rat kidneys", Hypertension, 72, pp.1151~1159 (2018)
- Yan Y, "Association between serum Klotho concentration and all-cause and cardiovascular mortality among American individuals with hypertension", Front Cardiovasc Med, 9, pp.1013747~ (2022)
- Yu J, "Association between serum Klotho concentration and hypertension in postmenopausal women, a cross-sectional study from NHANES 2013–2016", BMC Geriatr, 23, pp.466~ (2023)
- Wang Y, "Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage", Hypertension, 54, pp.810~817 (2009)
- Citterio L, "Klotho gene in human salt-sensitive hypertension", Clin J Am Soc Nephrol, 15, pp.375~383 (2020)